| Literature DB >> 27919265 |
Wineke Armbrust1, Otto H T M Lelieveld2, Jolanda Tuinstra3, Nico M Wulffraat4, G J F Joyce Bos2, Jeannette Cappon5, Marion A J van Rossum5, Pieter J J Sauer6, Mariët Hagedoorn3.
Abstract
BACKGROUND: Fatigue is common in patients with JIA and affects daily life negatively. We assessed the presence and severity of fatigue in patients with JIA, including factors presumed associated with fatigue (e.g., disease activity, disability, pain, physical activity, exercise capacity, and self-efficacy), and whether fatigue is related to participation in physical education classes, school attendance, and sports frequency.Entities:
Keywords: Exercise capacity; Fatigue; Juvenile idiopathic arthritis; Participation; Patient reported outcome; Physical activity; Self-efficacy
Mesh:
Year: 2016 PMID: 27919265 PMCID: PMC5139083 DOI: 10.1186/s12969-016-0125-1
Source DB: PubMed Journal: Pediatr Rheumatol Online J ISSN: 1546-0096 Impact factor: 3.054
Patient characteristics and outcome measurements of 80 patients with JIA
| Characteristic | M | [IQR] / (%) |
|---|---|---|
| Age | 9.8 | [8.7; 11.0] |
| Female |
| (65) |
| JIA classification | ||
| -Oligo-JIA, persistent |
| (31) |
| -Oligo-JIA, extended |
| (14) |
| -Poly-JIA, Rf- |
| (31) |
| -Poly-JIA, Rf+ |
| (4) |
| -Psoriasis related JIA |
| (5) |
| -Enthesitis related JIA |
| (4) |
| -S-JIA |
| (11) |
| Disease duration (yr) | 2.95 | [1.22; 6.19] |
| Disease activity (cm) | .30 | [.00; .90] |
| On medication |
| (75) |
| Disability | .33 | [.11; .75] |
| Pain (cm) | 1.50 | [.20; 3.85] |
| Fatigue | 77.8 | [68.1; 86.1] |
| Energy level (cm) | ||
| - Mean morning | 5.55 | [4.04; 8.14] |
| - Mean afternoon | 7.21 | [5.73; 8.39] |
| - Mean evening | 5.53 | [4.21; 7.57] |
| - Mean daily | 6.00 | [4.92; 7.49] |
| Number of days low/ very low energy ( | ||
| - 0 |
| (10/35) |
| - 1-3 |
| (13/38) |
| - 4-6 |
| (18/22) |
| - 7 |
| (60/7) |
| Exercise capacity | 592 | [489; 638] |
| PAL | 1.53 | [1.46; 1.60] |
| Participation PEC | ||
| -Full |
| (66) |
| -Partial |
| (28) |
| -No |
| (6) |
| Full school attendance |
| (70) |
| Sports frequency/week | 1 | [.25; 3.00] |
| Self-efficacy | ||
| -Symptom | 3.75 | [2.50; 6.72] |
| -Activity | 6.88 | [4.38; 9.38] |
M Median, IQR Inter Quartile Range, N Number, Rf Rheumatoid factor, yr years, cm centimeters, PAL Physical Activity Level, PEC Physical Education Class
Correlations with total fatigueR and energy levelMEAN
| Total fatigueR | Mean daily energy level | |||
|---|---|---|---|---|
| R | p | R | p | |
| Gender | .17 | .13 | -.22 | .06 |
| Age | .04 | .71 | -.15 | .18 |
| Disease activity | .08 | .46 | -.21 | .06 |
| Medication use | .12 | .29 | -.25 | .03 |
| Disability | .47 | < .01 | -.41 | < .01 |
| Pain | .38 | < .01 | -.35 | < .01 |
| Energy levelMEAN | -.52 | <.01 | ||
| EC | -.22 | .05 | .20 | .07 |
| PAL | -.30 | <.01 | .36 | <.01 |
| Self efficacySYMPTOM | -.25 | .02 | .12 | .30 |
| Self efficacyACTIVITY | -.44 | <.01 | .19 | .10 |
EC Exercise capacity, PAL Physical activity, Gender 1 = male; Medication use: 1 = yes
Prediction models for fatigueR and energy-levelMEAN
| FatigueR a | Energy-levelMEAN b | |||||
|---|---|---|---|---|---|---|
| B | p | CI | B | p | CI | |
| Estimate | .12 | .10 | −2.34; 2.58 | 7.48 | <.01 | 6.07; 8.91 |
| Gender | -.57 | .14 | −1.31; .18 | |||
| Disease actC | -.30 | .21 | -.78; .17 | |||
| Medication | -.43 | .32 | −1.26; .41 | |||
| Painc | .05 | .94 | −1.16; 1.26 | -.00 | .96 | -.18; .17 |
| Disabilityc | 8.72 | .01 | 2.00; 15.4 | −1.2 | <.01 | −2.15; −.33 |
| ECc | -.00 | .73 | -.03; .02 | .00 | .39 | -.00; .01 |
| PALc | −24.5 | .06 | 50.0; 1.05 | 4.8 | <.01 | 1.32; 8.33 |
| SEACTIVITYc | −1.16 | .04 | −2.24; −.08 | |||
| SESYMPTOMc | -.28 | .58 | −1.28; .72 | |||
aR2 = .32; bR2 = .30; EC Exercise capacity, PAL Physical activity, SE Self-efficacy Activity Scale, SE Self-efficacy Symptom Scale, Centered values; Gender 1 = male; Medication 1 = use of medication
Correlations with Total Participation in PEC, school attendance, and sports frequency
| School attendance | Full participation PEC | Sports frequency | ||||
|---|---|---|---|---|---|---|
| R | p | R | p | R | p | |
| Gender | .15 | .19 | -.19 | .09 | -.15 | .20 |
| Age | -.22 | .05 | -.20 | .08 | -.06 | .57 |
| Disease activity | -.22 | .05 | -.40 | <.01 | -.15 | .18 |
| Medication use | -.38 | <.01 | -.35 | <.01 | -.19 | .08 |
| Disability | -.29 | <.01 | -.58 | <.01 | -.19 | .10 |
| Pain | -.37 | <.01 | -.48 | <.01 | -.15 | .18 |
| FatigueR | -.20 | .07 | -.20 | .07 | -.30 | <.01 |
| EC | -.04 | .74 | .32 | <.01 | .11 | .34 |
| Self efficacySYM | .11 | .34 | .27 | .02 | .14 | .23 |
| Self efficacyACT | .11 | .34 | .26 | .02 | .03 | .79 |
PEC Physical Education Class, PAL Physical Activity Level
Prediction models for participation in PEC, school attendance, and sports frequency
| School attendancea | Full participation PECb | Sports frequencyc | |||||||
|---|---|---|---|---|---|---|---|---|---|
| B | p | SE | B | p | SE | B | p | 95%CI | |
| Gender | −1.83 | .15 | 1.26 | ||||||
| Age | -.35 | .11 | .22 | −1.29 | .04 | .64 | |||
| Dis act | -.06 | .87 | .37 | −1.53 | .06 | .81 | |||
| Medication | -.20.4 | 1.0 | 8.6x103 | −3.31 | .04 | 1.62 | -.43 | .21 | −1.13; .25 |
| Disab. c | -.13 | .88 | .85 | −4.90 | .02 | 2.06 | |||
| Painc | -.32 | .02 | .14 | -.69 | .02 | .29 | |||
| FatigueRc | -.09 | .75 | .03 | .14 | .04 | .07 | -.03 | .01 | -.05; −.01 |
| ECc | .02 | .03 | .01 | ||||||
| SESYMpTOMc | .03 | .25 | 1.34 | ||||||
| SEACTIVITYc | .12 | .15 | 2.05 | ||||||
| Est | 21.0 | .99 | 8.6x103 | 4.34 | .01 | 1.58 | 1.96 | <.01 | 1.37;2.56 |
aR2 Nagelkerke .46 (logistic regression); bR2Nagelkerke .82 (logistic regression); cR2 = .10 Multilevel regression analysis. Participation: 1 = total participation; School attendance, 1 = full attendance during the previous 3 months; gender: 1 = male; medication: 1 = yes; dis act = disease activity; diasb. disability, fatigue reversed fatigue scale, EC exercise capacity. SE self-efficacy, est estimate, centered values
Results of the multivariate analysis of FatigueR exploring interaction
| B | p | CI | |
|---|---|---|---|
| Estimate | 22.5 | . < 01 | 19.8; 25.1 |
| EC c | -.02 | .14 | -,05; .01 |
| SEACTIVITY c | −1.94 | <.01 | −3.0; −.94 |
| EC c *SEACTIVITY c | ,00 | .49 | -,01; .02 |
| Estimate | 22.6 | <.01 | 80.0; 74,8 |
| PAL c | −28.9 | .04 | −55.2; −1.93 |
| SEACTIVITY c | −1.85 | <.01 | −2.8; −.92 |
| PAL c *SEACTIVITY c | -.99 | .85 | −11.6; 9.63 |
| Estimate | 22.4 | <.01 | 19.8; 25.1 |
| Pain c | 1.45 | .01 | .42; 2.5 |
| SESYMPTOMS c | −1.26 | .01 | −2.2; −.35 |
| Pain*SESYMPTOMS c | -.07 | .66 | -.41; .26 |
| Estimate | 22.6 | <.01 | 19.9; 25.2 |
| Dysability c | 10.9 | <.01 | 5.3; 16.5 |
| SESYMPTOMS c | -.82 | .09 | −1.77; .13 |
| Dysability c *SESYMPTOMS c | .27 | .80 | −1.85; 2.39 |
EC exercise capacity, SE self efficacy, centered values
* multiply